Teriparatide ups bone union for women with osteoporosis

Teriparatide ups bone union for women with osteoporosis
Injections of teriparatide are more effective than oral bisphosphonate for bone union after instrumented lumbar posterolateral fusion in women with postmenopausal osteoporosis, according to a study published in the Nov. 1 issue of Spine.

(HealthDay)—Injections of teriparatide are more effective than oral bisphosphonate for bone union after instrumented lumbar posterolateral fusion in women with postmenopausal osteoporosis, according to a study published in the Nov. 1 issue of Spine.

Seiji Ohtori, M.D., Ph.D., from Chiba University in Japan, and colleagues examined the clinical efficacy of teriparatide for bone union in 57 women with osteoporosis diagnosed with degenerative spondylolisthesis who underwent decompression and one- or two-level instrumented posterolateral fusion with a local . Patients were divided into a teriparatide treatment group (29 patients receiving daily subcutaneous injection of 20 µg teriparatide) or group (28 women receiving weekly oral administration of 17.5 mg of risedronate).

The researchers found that pain scores improved after surgery but that there were no significant between-group differences. In the teriparatide group, the rate of bone union was 82 percent, compared with 68 percent in the bisphosphonate group, and the average duration of bone union was eight and 10 months, respectively. Both the rate of bone union and average duration of bone union were significantly superior in the teriparatide group versus the bisphosphonate group.

"The teriparatide-treated patients showed superior results in the rate of bone union and average duration of bone union compared with the bisphosphonate-treated patients," the authors write. "We think that can enhance in patients with osteoporosis."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Instrumented spinal fusion method impacts infection rate

May 21, 2012

(HealthDay) -- For patients who undergo instrumented spinal fusion, the rates of infection are higher among those who receive posterior lumbar interbody fusion compared with those who receive posterior or ...

Recommended for you

Sleep duration affects risk for ulcerative colitis

27 minutes ago

If you are not getting the recommended seven-to-eight hours of sleep each night, you may be at increased risk of developing ulcerative colitis, according to a new study1 in Clinical Gastroenterology and Hepatolog ...

User comments